Marc-André Champigny Marc-André Champigny

Medici Technologies Inc. (dba Livewell) in its sale to Hims & Hers

On December 4, 2025, Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, announced its expansion into Canada through its acquisition of Medici Technologies Inc. (dba Livewell). Livewell is a trusted Canadian digital health platform focused...

Lead Office: Montreal Date Announced: December 4, 2025 Value: --

Deep Sky in its securing of US$40-million grant from Breakthrough Energy Catalyst

On December 18, 2024, Deep Sky announced it secured a US$40-million grant from Breakthrough Energy Catalyst. These funds will be utilized towards research and testing of direct air capture technologies. It is noted that this is Breakthrough Energy Catalyst's first-ever investment in both a...

Lead Office: Montreal Date Announced: December 18, 2024 Value: US$40 million

Deck Software in its raising of $6.2 million of Seed financing

On October 15, 2024, Deck Software announced that it raised $6.2 million in a Seed financing round. This all-equity, all-primary round was co-led by Golden Ventures and Better Tomorrow Ventures. This round also saw participation from Luge Capital. Deck Software is a new application programming...

Lead Office: Toronto Date Announced: October 15, 2024 Value: $6.2 million

Motion Creative Cloud in its raising of US$30-million Series B financing

On September 19, 2024, Motion Creative Cloud announced its raising of US$30 million in a Series B financing round. This round was led by Inovia Capital and saw participation from Threshold Ventures and other existing investors including Silicon Valley investors: Headline, Abstract Ventures and...

Lead Office: Toronto Date Announced: September 19, 2024 Value: US$30 million

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and...

Lead Office: Montreal Date Closed: -- Value: US$1.075 billion